BRAF and melanoma: Although lack of USP28 expression in melanoma cells has no impact on cell proliferation, it favors both the development of resistance to BRAF/MEK inhibitor combination therapies in vitro and in vivo and the generation of emergent tumor cells in mouse xenograft experiments.